Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms

A Inserra, D De Gregorio, G Gobbi - Pharmacological Reviews, 2021 - ASPET
Mounting evidence suggests safety and efficacy of psychedelic compounds as potential
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …

The role of serotonin in drug use and addiction

CP Müller, JR Homberg - Behavioural brain research, 2015 - Elsevier
The use of psychoactive drugs is a wide spread behaviour in human societies. The
systematic use of a drug requires the establishment of different drug use-associated …

The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA,“ecstasy”)

AR Green, AO Mechan, JM Elliott, E O'Shea… - Pharmacological …, 2003 - ASPET
The amphetamine derivative (±)-3, 4-methylenedioxymethamphetamine (MDMA, ecstasy) is
a popular recreational drug among young people, particularly those involved in the dance …

Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors

CP Müller, RJ Carey, JP Huston, MADS Silva - Progress in neurobiology, 2007 - Elsevier
Serotonin1A-receptors (5-HT1A-Rs) are important components of the 5-HT system in the
brain. As somatodendritic autoreceptors they control the activity of 5-HT neurons, and, as …

Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone

R López‐Arnau, J Martínez‐Clemente… - British journal of …, 2012 - Wiley Online Library
BACKGROUND AND PURPOSE Here, we have compared the neurochemical profile of
three new cathinones, butylone, mephedrone and methylone, in terms of their potential to …

Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies

ME Liechti, FX Vollenweider - … : Clinical and Experimental, 2001 - Wiley Online Library
Abstract In preclinical studies, 3, 4‐methylenedioxymethamphetamine (MDMA,'Ecstasy') has
been shown to release serotonin (5‐HT), dopamine and norepinephrine. However, the role …

Serotonin: from top to bottom

S Fidalgo, DK Ivanov, SH Wood - Biogerontology, 2013 - Springer
Serotonin is a monoamine neurotransmitter, which is phylogenetically conserved in a wide
range of species from nematodes to humans. In mammals, age-related changes in serotonin …

Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms

J Lyles, JL Cadet - Brain Research Reviews, 2003 - Elsevier
Methylenedioxymethamphetamine (MDMA, Ecstasy) is a very popular drug of abuse. This
has led to new intense concerns relevant to its nefarious neuropsychiatric effects. These …

[HTML][HTML] Use and abuse of dissociative and psychedelic drugs in adolescence

MLS Bates, KA Trujillo - Pharmacology Biochemistry and Behavior, 2021 - Elsevier
Adolescence is a period of profound developmental changes, which run the gamut from
behavioral and neural to physiological and hormonal. It is also a time at which there is an …

Perspectives for the development of animal models of bipolar disorder

R Machado-Vieira, F Kapczinski, JC Soares - Progress in Neuro …, 2004 - Elsevier
Bipolar disorder (BD) has been a particularly challenging illness for the development of
adequate animal models for neurobiological studies. These difficulties are largely related to …